The prevalence of aminoglycoside-modifying enzyme genes among Pseudomonas aeruginosa strains isolated from burn patients

Archives of Clinical Infectious Diseases

Volumn 12, Issue 1, 2017, Pages

  Kashfi, Mojtaba ^a   Hashemi, Ali ^a   Eslami, Gita ^a   Amin, Mehrzad Sadredin ^a   Tarashi, Samira ^a   Taki, Elahe ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aminoglycoside modifying enzymes; Aminoglycosides; Burn Patient; Multi drug resistance (MDR); P. Aeruginosa

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DORIPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN;

AAC (6') IIA GENE; AADA GENE; AADB GENE; AMINOGLYCOSIDE-MODIFYING ENZYME GENE; ANTIBIOTIC RESISTANCE; APH (3')-IB GENE; APH(6')-VI GENE; ARMA GENE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURN PATIENT; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISK DIFFUSION; GENE IDENTIFICATION; HOSPITAL PATIENT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREVALENCE; PSEUDOMONAS AERUGINOSA; RMTA GENE;

EID: 85011665540     PISSN: 23452641     EISSN: 20081081     Source Type: Journal    
DOI: 10.5812/archcid.40896     Document Type: Article

References (25)

1. Heidary M, Hashemi A, Goudarzi H, Khoshnood S, Roshani M, Azimi H. The antibacterial activity of Iranian plants extracts against metallo beta-lactamase producing Pseudomonas aeruginosa strains. J Paramed Sci. 2016;7(1).
2. Park YS, Lee H, Chin BS, Han SH, Hong SG, Hong SK, et al. Acquisition of extensive drug-resistant Pseudomonas aeruginosa among hospitalized patients: risk factors and resistance mechanisms to carbapenems. J Hosp Infect. 2011;79(1):54–8. doi: 10.1016/j.jhin.2011.05.014. [PubMed: 21764173].
3. Tadvi J, Javadekar T, Bhavsar R, Garala N. Prevalence & antibiogram of Pseudomonas aeruginosa at SSG Hospital, Baroda, Gujarat, India. J Res Med Dental Sci. 2015;3(3):204–7. doi: 10.5455/jrmds.20153310.
4. Hashemi A, Fallah F, Erfanimanesh S, Chirani AS, Dadashi M. Detection of Antibiotic Resistance Genes among Pseudomonas aeruginosa Strains Isolated from Burn Patients in Iran. British Microbiol Res J. 2016;12(4):1–6.
5. Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2011;2:65. doi: 10.3389/fmicb.2011.00065. [PubMed: 21747788].
6. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005;49(2):479–87. doi: 10.1128/AAC.49.2.479-487.2005. [PubMed: 15673721].
7. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updat. 2010;13(6):151–71. doi: 10.1016/j.drup.2010.08.003. [PubMed: 20833577].
8. Doi Y, Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis. 2007;45(1):88–94. doi: 10.1086/518605. [PubMed: 17554708].
9. Yamane K, Doi Y, Yokoyama K, Yagi T, Kurokawa H, Shibata N, et al. Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2004;48(6):2069–74. doi: 10.1128/AAC.48.6.2069-2074.2004. [PubMed: 15155201].
10. Zhou Y, Yu H, Guo Q, Xu X, Ye X, Wu S, et al. Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides. Eur J Clin Microbiol Infect Dis. 2010;29(11):1349–53. doi: 10.1007/s10096-010-1004-1. [PubMed: 20614151].
11. Wayne P. Clinical and Laboratory Standards Institute (CLSI) performance standards for antimicrobial disk diffusion susceptibility tests. 2015.
12. Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49(11):1749–55. doi: 10.1086/647952. [PubMed: 19857164].
13. Aghazadeh M, Rezaee MA, Nahaei MR, Mahdian R, Pajand O, Saffari F, et al. Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among acinetobacter baumannii and Pseudomonas aeruginosa isolates. Microb Drug Resist. 2013;19(4):282–8. doi: 10.1089/mdr.2012.0223. [PubMed: 23577624].
14. Asadollahi P, Akbari M, Soroush S, Taherikalani M, Asadollahi K, Sayehmiri K, et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns. 2012;38(8):1198–203. doi: 10.1016/j.burns.2012.04.008. [PubMed: 22579564].
15. Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, Andre C, et al. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J Antimicrob Chemother. 2008;62(2):316–23. doi: 10.1093/jac/dkn174. [PubMed: 18467306].
16. Chatterjee M, Anju CP, Biswas L, Anil Kumar V, Gopi Mohan C, Biswas R. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options. Int J Med Microbiol. 2016;306(1):48–58. doi: 10.1016/j.ijmm.2015.11.004. [PubMed: 26687205].
17. Rastegar Lari AR, Alaghehbandan R, Akhlaghi L. Burn wound infections and antimicrobial resistance in tehran, iran: an increasing problem. Ann Burns Fire Disasters. 2005;18(2):68–73. [PubMed: 21990981].
18. Kiani M, Zandi H, Astani A, Vakili M, Musavi M, Zarei M. Investigating Antibiotic Resistance in Pseudomonas Aeruginosa Strains Isolated from Various Clinical Specimens of Patients Referring to Hospitals in Yazd. J Shahid Sadoughi Uni Med Sci. 2015;22(6):1644–53.
19. Goudarzi H, Taherpour A, Fallah F, Pourkaveh B, Erfanimanesh S, Hashemi A. Laboratory Detection of Carbapenemases in Gram- Negative Bacteria. Arch Clin Infect Dis. 2016;inpress(inpress) doi: 10.5812/archcid.32816.
20. Michalska AD, Sacha PT, Ojdana D, Wieczorek A, Tryniszewska E. Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland. Braz J Microbiol. 2014;45(4):1455–8. doi: 10.1590/S1517-83822014000400041. [PubMed: 25763054].
21. Bhatt P, Rathi KR, Hazra S, Sharma A, Shete V. Prevalence of multidrug resistant Pseudomonas aeruginosa infection in burn patients at a tertiary care centre. India J Burns. 2015;23(1):56. doi: 10.4103/0971-653X.171656.
22. Vaziri F, Peerayeh SN, Nejad QB, Farhadian A. The prevalence of aminoglycoside-modifying enzyme genes (aac (6’)-I, aac (6’)-II, ant (2")-I, aph (3’)-VI) in Pseudomonas aeruginosa. Clinics (Sao Paulo). 2011;66(9):1519–22. [PubMed: 22179152].
23. Jafari M, Fallah F, Borhan RS, Navidinia M, Karimi A, Tabatabaei SR. The first report of CMY, aac (60)-Ib and 16S rRNA methylase genes among Pseudomonas aeruginosa isolates from Iran. Arch Pediatr Infect Dis. 2013;1(3):109–12. doi: 10.5812/pedinfect.11392.
24. Li J, Zou M, Dou Q, Hu Y, Wang H, Yan Q, et al. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in theHunan province of China. Ann Clin Microbiol Antimicrob. 2016;15(1):35. doi: 10.1186/s12941-016-0148-y. [PubMed: 27215335].
25. Odumosu BT, Adeniyi BA, Chandra R. Occurrence of aminoglycosidemodifying enzymes genes (aac(6’)-I and ant(2”)-I) in clinical isolates of Pseudomonas aeruginosa from Southwest Nigeria. Afr Health Sci. 2015;15(4):1277–81. doi: 10.4314/ahs.v15i4.29. [PubMed: 26958031].